Arcturus appoints Slaoui chair designate
BioCentury
by
9h ago
FEB 05, 2025 | 6:26 PM PST | BIOCENTURY | MANAGEMENT TRACKS ARCTURUS APPOINTS SLAOUI CHAIR DESIGNATE BY Plus: Affinia hires Makimura and Xu joins Sciwindhttps://www.biocentury.com/article/654979/arcturus-appoints-slaoui-chair-designate© 2025 BioCentury Inc. All Rights Reserved ..read more
Visit website
Bill expanding IRA orphan exemption introduced
BioCentury
by
9h ago
FEB 05, 2025 | 6:23 PM PST | BIOCENTURY | POLITICS, POLICY & LAW BILL EXPANDING IRA ORPHAN EXEMPTION INTRODUCED BY ORPHAN Cures seeks to lift restriction on number of orphan indications exempt from Medicare price negotiationshttps://www.biocentury.com/article/654985/bill-expanding-ira-orphan-exemption-introduced© 2025 BioCentury Inc. All Rights Reserved ..read more
Visit website
Call to action: Defending the NIH, the NSF and the foundation of American science — a Guest Commentary
BioCentury
by
9h ago
FEB 05, 2025 | 6:21 PM PST | BIOCENTURY | GUEST COMMENTARY CALL TO ACTION: DEFENDING THE NIH, THE NSF AND THE FOUNDATION OF AMERICAN SCIENCE — A GUEST COMMENTARY BY There is an assault on the foundation of U.S. science: Silence is not an optionhttps://www.biocentury.com/article/654982/call-to-action-defending-the-nih-the-nsf-and-the-foundation-of-american-science-a-guest-commentary© 2025 BioCentury Inc. All Rights Reserved ..read more
Visit website
Cardiometabolic wins among highlights in BioCentury’s latest Clinical Report
BioCentury
by
9h ago
FEB 05, 2025 | 5:29 PM PST | BIOCENTURY | PRODUCT DEVELOPMENT CARDIOMETABOLIC WINS AMONG HIGHLIGHTS IN BIOCENTURY’S LATEST CLINICAL REPORT BY Plus readouts from Allakos, Leap, Cargo and morehttps://www.biocentury.com/article/654975/cardiometabolic-wins-among-highlights-in-biocentury-s-latest-clinical-report© 2025 BioCentury Inc. All Rights Reserved ..read more
Visit website
ElevAAte: Cultivating the next generation of East Asian American leaders
BioCentury
by
9h ago
FEB 05, 2025 | 5:05 PM PST | BIOCENTURY | MANAGEMENT TRACKS ELEVAATE: CULTIVATING THE NEXT GENERATION OF EAST ASIAN AMERICAN LEADERS BY The non-profit launches to overcome C-suite underrepresentation by helping U.S. biopharma leaders of East Asian descent advance in their careershttps://www.biocentury.com/article/654632/elevaate-cultivating-the-next-generation-of-east-asian-american-leaders© 2025 BioCentury Inc. All Rights Reserved ..read more
Visit website
Novo believes new CagriSema trial can hit weight loss goal
BioCentury
by
9h ago
FEB 05, 2025 | 4:55 PM PST | BIOCENTURY | PRODUCT DEVELOPMENT NOVO BELIEVES NEW CAGRISEMA TRIAL CAN HIT WEIGHT LOSS GOAL BY Aims to drive additional weight loss after analysis of Phase III REDEFINE 1 obesity datahttps://www.biocentury.com/article/654974/novo-believes-new-cagrisema-trial-can-hit-weight-loss-goal© 2025 BioCentury Inc. All Rights Reserved ..read more
Visit website
Biotechs make inroads to precision medicine, solving long-standing problems
BioCentury
by
9h ago
FEB 05, 2025 | 3:53 PM PST | BIOCENTURY | PRODUCT DEVELOPMENT BIOTECHS MAKE INROADS TO PRECISION MEDICINE, SOLVING LONG-STANDING PROBLEMS BY 70% of new precision medicines approved by FDA in past three years were not sponsored by major pharmashttps://www.biocentury.com/article/654884/biotechs-make-inroads-to-precision-medicine-solving-long-standing-problems© 2025 BioCentury Inc. All Rights Reserved ..read more
Visit website
Australian radiopharma play Advancell taps VCs for $112M in ‘scale capital’
BioCentury
by
9h ago
FEB 04, 2025 | 12:30 PM PST | BIOCENTURY | FINANCE AUSTRALIAN RADIOPHARMA PLAY ADVANCELL TAPS VCS FOR $112M IN ‘SCALE CAPITAL’ BY Expanding in U.S., the biotech will build manufacturing capacity for α-emitters, including clinical program for prostate cancerhttps://www.biocentury.com/article/654951/australian-radiopharma-play-advancell-taps-vcs-for-112m-in-scale-capital© 2025 BioCentury Inc. All Rights Reserved ..read more
Visit website
Management changes at Astellas
BioCentury
by
1d ago
FEB 04, 2025 | 5:35 PM PST | BIOCENTURY | MANAGEMENT TRACKS MANAGEMENT CHANGES AT ASTELLAS BY Plus: Lundbeck board planning to elect Dorothea Wenzel chair, and updates from PacBio and Uvax Biohttps://www.biocentury.com/article/654953/management-changes-at-astellas© 2025 BioCentury Inc. All Rights Reserved ..read more
Visit website
Cassidy’s support paves path for RFK Jr. confirmation
BioCentury
by
1d ago
FEB 04, 2025 | 5:07 PM PST | BIOCENTURY | POLITICS, POLICY & LAW CASSIDY’S SUPPORT PAVES PATH FOR RFK JR. CONFIRMATION BY Vaccine critic, conspiracy promoter on track to be next HHS secretaryhttps://www.biocentury.com/article/654956/cassidy-s-support-paves-path-for-rfk-jr-confirmation© 2025 BioCentury Inc. All Rights Reserved ..read more
Visit website

Follow BioCentury on FeedSpot

Continue with Google
Continue with Apple
OR